- Student Records
Programme & Unit Catalogues


PA30150: Cardiovascular pharmacology

Follow this link for further information on academic years Academic Year: 2012/3
Follow this link for further information on owning departmentsOwning Department/School: Department of Pharmacy & Pharmacology
Follow this link for further information on credits Credits: 6
Follow this link for further information on unit levels Level: Honours (FHEQ level 6)
Follow this link for further information on period slots Period: Semester 2
Follow this link for further information on unit assessment Assessment: EX 100%
Follow this link for further information on supplementary assessment Supplementary Assessment: Like-for-like reassessment (where allowed by programme regulations)
Follow this link for further information on unit rules Requisites:
Follow this link for further information on unit content Description: Aims:
The aims of this unit are to provide a knowledge base of recent developments in understanding the cardivascular system and its role in human diseases, and to examine how such understanding can lead to identification and exploitation of novel drug targets for future therapy.

Learning Outcomes:
On successful completion of this unit, the student should be able to: demonstrate knowledge and understanding of recently identified target molecules and processes in the cardiovascular system, give examples of the role of these targets in particular therapeutic areas and utilise a range of ICT and cognitive skills in acquiring knowledge and understanding and applying them to given situations.

Skills:
Scientific skills (T/F/A)
Study skills, handling information, working with others (T/F)
Problem solving (T/F).

Content:
Following an introduction and brief overview of earlier core units, a number of topics will be discussed covering recent advances in cardiovascular pharmacology. Topics will be selected on the basis of their currency at a given time - examples may include regulation of blood vessel tone, calcium and potassium channels, endothelium-derived vasorelaxant factors, vascular disease, including stroke and pulmonary hypertension; blood platelet regulatory mechanisms, cardiac arrythmia and channelopathies, including long QT-syndrome.
Follow this link for further information on programme availabilityProgramme availability:

PA30150 is Optional on the following programmes:

Programmes in Natural Sciences
  • UXXX-AFB01 : BSc (hons) Natural Sciences (Full-time) - Year 3
  • UXXX-AKB02 : BSc (hons) Natural Sciences with Industrial Placement (Full-time with Thick Sandwich Placement) - Year 4
  • UXXX-AAB02 : BSc (hons) Natural Sciences with Study Year Abroad (Full-time with Study Year Abroad) - Year 4
  • UXXX-AFM01 : MSci (hons) Natural Sciences (Full-time) - Year 3
  • UXXX-AKM02 : MSci (hons) Natural Sciences with Professional Placement (Full-time with Thick Sandwich Placement) - Year 4
  • UXXX-AAM02 : MSci (hons) Natural Sciences with Study Year Abroad (Full-time with Study Year Abroad) - Year 4
Department of Pharmacy & Pharmacology
  • USPA-AFB02 : BSc (hons) Pharmacology (Full-time) - Year 3
  • USPA-AKB02 : BSc (hons) Pharmacology (Full-time with Thick Sandwich Placement) - Year 4

Notes:
* This unit catalogue is applicable for the 2012/13 academic year only. Students continuing their studies into 2013/14 and beyond should not assume that this unit will be available in future years in the format displayed here for 2012/13.
* Programmes and units are subject to change at any time, in accordance with normal University procedures.
* Availability of units will be subject to constraints such as staff availability, minimum and maximum group sizes, and timetabling factors as well as a student's ability to meet any pre-requisite rules.